Epigallocatechin gallate targeting of membrane type 1 matrix metalloproteinase-mediated src and janus kinase/signal transducers and activators of transcription 3 signaling inhibits transcription of colony-stimulating factors 2 and 3 in mesenchymal stromal cells

Journal of Biological Chemistry

Volumn 288, Issue 19, 2013, Pages 13378-13386

  Zgheib, Alain ^a   Lamy, Sylvie ^a   Annabi, Borhane ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOPREVENTIVE; COLONY-STIMULATING FACTOR; EPIGALLOCATECHIN GALLATE; IMMUNOMODULATORY; INTRACELLULAR SIGNALING; MESENCHYMAL STROMAL CELLS; TRANSCRIPTIONAL REGULATION; TUMOR DEVELOPMENT;

CELL CULTURE; FLOWCHARTING; TRANSCRIPTION;

CELL SIGNALING;

EPIGALLOCATECHIN GALLATE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MATRIX METALLOPROTEINASE 14; PROTEIN TYROSINE KINASE; STAT3 PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG TARGETING; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; MUTANT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANGIOGENESIS; CANCER CHEMOPREVENTION; CYTOKINE INDUCTION; GREEN TEA EGCG; MATRIX METALLOPROTEINASE (MMP); MESENCHYMAL STEM CELLS;

ANGIOGENESIS INHIBITORS; CATECHIN; CELLS, CULTURED; CONCANAVALIN A; GENE SILENCING; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; JANUS KINASES; MACROPHAGE COLONY-STIMULATING FACTOR; MATRIX METALLOPROTEINASE 14; MESENCHYMAL STROMAL CELLS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 6; TRANSCRIPTION, GENETIC;

EID: 84877702897     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.456533     Document Type: Article

References (47)

1. Sassoli, C., Zecchi-Orlandini, S., and Formigli, L. (2012) Trophic actions of bone marrow-derived mesenchymal stromal cells for muscle repair/regeneration. Cells 1, 832-850
2. Meirelles Lda, S., Fontes, A. M., Covas, D. T., and Caplan, A. I. (2009) Mechanisms involved in the therapeutic properties of mesenchymal stem cells. Cytokine Growth Factor Rev. 20, 419-427
3. Lin, R. Z., Moreno-Luna, R., Zhou, B., Pu, W. T., and Melero-Martin, J. M. (2012) Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells. Angiogenesis 15, 443-455
4. Annabi, B., Naud, E., Lee, Y. T., Eliopoulos, N., and Galipeau, J. (2004) Vascular progenitors derived from murine bone marrow stromal cells are regulated by fibroblast growth factor and are avidly recruited by vascularizing tumors. J. Cell. Biochem. 91, 1146-1158
5. Birnbaum, T., Roider, J., Schankin, C. J., Padovan, C. S., Schichor, C., Goldbrunner, R., and Straube, A. (2007) Malignant gliomas actively recruit bone marrow stromal cells by secreting angiogenic cytokines. J. Neurooncol. 83, 241-247
6. Huang, W. H., Chang, M. C., Tsai, K. S., Hung, M. C., Chen, H. L., and Hung, S. C. (October 22, 2012) Mesenchymal stem cells promote growth and angiogenesis of tumors in mice. Oncogene, 10.1038/onc.2012.458
7. Mirotsou, M., Jayawardena, T. M., Schmeckpeper, J., Gnecchi, M., and Dzau, V. J. (2011) Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J. Mol. Cell. Cardiol. 50, 280-289
8. Ribatti, D. (2012) Angiogenic activity of classical hematopoietic cytokines. Leuk. Res. 36, 537-543
9. Bussolino, F., Wang, J. M., Defilippi, P., Turrini, F., Sanavio, F., Edgell, C. J., Aglietta, M., Arese, P., and Mantovani, A. (1989) Granulocyte-and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 377, 471-473
10. Bocchietto, E., Guglielmetti, A., Silvagno, F., Taraboletti, G., Pescarmona, G. P., Mantovani, A., and Bussolino, F. (1993) Proliferative and migratory responses of murine microvascular endothelial cells to granulocyte-colony-stimulating factor. J. Cell. Physiol. 155, 89-95
11. Bussolino, F., Ziche, M., Wang, J. M., Alessi, D., Morbidelli, L., Cremona, O., Bosia, A., Marchisio, P. C., and Mantovani, A. (1991) In vitro and in vivo activation of endothelial cells by colony-stimulating factors. J. Clin. Invest. 87, 986-995
12. Akla, N., Pratt, J., and Annabi, B. (2012) Concanavalin-A triggers inflammatory response through JAK/STAT3 signalling and modulates MT1-MMP regulation of COX-2 in mesenchymal stromal cells. Exp. Cell Res. 318, 2498-2506
13. Annabi, B., Thibeault, S., Lee, Y. T., Bousquet-Gagnon, N., Eliopoulos, N., Barrette, S., Galipeau, J., and Béliveau, R. (2003) Matrix metalloproteinase regulation of sphingosine 1-phosphate-induced angiogenic properties of bone marrow stromal cells. Exp. Hematol. 31, 640-649
14. Meriane, M., Duhamel, S., Lejeune, L., Galipeau, J., and Annabi, B. (2006) Cooperation of matrix metalloproteinases with the RhoA/Rho kinase and mitogen-activated protein kinase kinase-1/extracellular signal-regulated kinase signaling pathways is required for the sphingosine 1-phosphateinduced mobilization of marrow-derived stromal cells. Stem Cells 24, 2557-2565
15. Annabi, B., Thibeault, S., Moumdjian, R., and Béliveau, R. (2004) Hyaluronan cell surface binding is induced by type I collagen and regulated by caveolae in glioma cells. J. Biol. Chem. 279, 21888-21896
16. Lord-Dufour, S., Copland, I. B., Levros, L. C., Jr., Post, M., Das, A., Khosla, C., Galipeau, J., Rassart, E., and Annabi, B. (2009) Evidence for transcriptional regulation of the glucose 6-phosphate transporter by HIF-1α: targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells. Stem Cells 27, 489-497
17. Nyalendo, C., Beaulieu, E., Sartelet, H., Michaud, M., Fontaine, N., Gingras, D., and Béliveau, R. (2008) Impaired tyrosine phosphorylation of membrane type 1 matrix metalloproteinase reduces tumor cell proliferation in three-dimensional matrices and abrogates tumor growth in mice. Carcinogenesis 29, 1655-1664
18. Currie, J. C., Fortier, S., Sina, A., Galipeau, J., Cao, J., and Annabi, B. (2007) MT1-MMP down-regulates the glucose 6-phosphate transporter expression in marrow stromal cells: a molecular link between pro-MMP-2 activation, chemotaxis, and cell survival. J. Biol. Chem. 282, 8142-8149
19. Bauvois, B. (2004) Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 23, 317-329
20. Abarrategi, A., Marińas-Pardo, L., Mirones, I., Rincón, E., and García-Castro, J. (2011) Mesenchymal niches of bone marrow in cancer. Clin. Transl. Oncol. 13, 611-616
21. Moss, N. M., Wu, Y. I., Liu, Y., Munshi, H. G., and Stack, M. S. (2009) Modulation of the membrane type 1 matrix metalloproteinase cytoplasmic tail enhances tumor cell invasion and proliferation in three-dimensional collagen matrices. J. Biol. Chem. 284, 19791-19799
22. Gonzalo, P., Moreno, V., Gálvez, B. G., and Arroyo, A. G. (2010) MT1-MMP and integrins: hand-to-hand in cell communication. Biofactors 36, 248-254
23. Eisenach, P. A., Roghi, C., Fogarasi, M., Murphy, G., and English, W. R. (2010) MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src. J. Cell Sci. 123, 4182-4193
24. + hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1. Blood 97, 3433-3440
25. Sun, X. T., Yuan, X. W., Zhu, H. T., Deng, Z. M., Yu, D. C., Zhou, X., and Ding, Y. T. (2012) Endothelial precursor cells promote angiogenesis in hepatocellular carcinoma. World J. Gastroenterol. 18, 4925-4933
26. Yoshioka, T., Takahashi, M., Shiba, Y., Suzuki, C., Morimoto, H., Izawa, A., Ise, H., and Ikeda, U. (2006) Granulocyte colony-stimulating factor (G-CSF) accelerates reendothelialization and reduces neointimal formation after vascular injury in mice. Cardiovasc. Res. 70, 61-69
27. Kanellopoulos, J. M., De Petris, S., Leca, G., and Crumpton, M. J. (1985) The mitogenic lectin from Phaseolus vulgaris does not recognize the T3 antigen of human T lymphocytes. Eur. J. Immunol. 15, 479-486
28. Ferriz-Martinez, R. A., Torres-Artega, I. C., Blanco-Labra, A., and Garcia-Gasca, T. (2010) The role of plant lectins in cancer treatment. Nova Sci. 71-90
29. Goutagny, N., Estornes, Y., Hasan, U., Lebecque, S., and Caux, C. (2012) Targeting pattern recognition receptors in cancer immunotherapy. Target. Oncol. 7, 29-54
30. Grote, K., Schütt, H., and Schieffer, B. (2011) Toll-like receptors in angiogenesis. Sci. World J. 11, 71-90
31. Kong, Y., and Le, Y. (2011) Toll-like receptors in inflammation of the central nervous system. Int. Immunopharmacol. 11, 1407-1414
32. Strongin, A. Y. (2010) Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy. Biochim. Biophys. Acta 1803, 133-141
33. Arroyo, A. G., Genís, L., Gonzalo, P., Matías-Román, S., Pollán, A., and Gálvez, B. G. (2007) Matrix metalloproteinases: new routes to the use of MT1-MMP as a therapeutic target in angiogenesis-related disease. Curr. Pharm. Des. 13, 1787-1802
34. Byun, E. B., Choi, H. G., Sung, N. Y., and Byun, E. H. (2012) Green tea polyphenol epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor on lipopolysaccharide-stimulated dendritic cells. Biochem. Biophys. Res. Commun. 426, 480-485
35. Byun, E. H., Omura, T., Yamada, K., and Tachibana, H. (2011) Green tea polyphenol epigallocatechin-3-gallate inhibits TLR2 signaling induced by peptidoglycan through the polyphenol sensing molecule 67-kDa laminin receptor. FEBS Lett. 585, 814-820
36. Annabi, B., Lachambre, M. P., Bousquet-Gagnon, N., Page, M., Gingras, D., and Beliveau, R. (2002) Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim. Biophys. Acta 1542, 209-220
37. Pratt, J., Roy, R., and Annabi, B. (2012) Concanavalin-A-induced autophagy biomarkers requires membrane type-1 matrix metalloproteinase intracellular signaling in glioblastoma cells. Glycobiology 22, 1245-1255
38. + U87 glioblastoma cells. J. Neuroinflammation 6, 8
39. Eisenach, P. A., de Sampaio, P. C., Murphy, G., and Roghi, C. (2012) Membrane type 1 matrix metalloproteinase (MT1-MMP) ubiquitination at Lys-581 increases cellular invasion through type I collagen. J. Biol. Chem. 287, 11533-11545
40. Nyalendo, C., Michaud, M., Beaulieu, E., Roghi, C., Murphy, G., Gingras, D., and Béliveau, R. (2007) Src-dependent phosphorylation of membrane type I matrix metalloproteinase on cytoplasmic tyrosine 573: role in endothelial and tumor cell migration. J. Biol. Chem. 282, 15690-15699
41. Yang, C. S., Chen, L., Lee, M. J., Balentine, D., Kuo, M. C., and Schantz, S. P. (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol. Biomarkers Prev. 7, 351-354
42. Remacle, A. G., Golubkov, V. S., Shiryaev, S. A., Dahl, R., Stebbins, J. L., Chernov, A. V., Cheltsov, A. V., Pellecchia, M., and Strongin, A. Y. (2012) Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth. Cancer Res. 72, 2339-2349
43. Sina, A., Lord-Dufour, S., and Annabi, B. (2009) Cell-based evidence for aminopeptidase N/CD13 inhibitor actinonin targeting of MT1-MMPmediated proMMP-2 activation. Cancer Lett. 279, 171-176
44. Ingvarsen, S., Porse, A., Erpicum, C., Maertens, L., Jürgensen, H. J., Madsen, D. H., Melander, M. C., Gårdsvoll, H., Høyer-Hansen, G., Noel, A., Holmbeck, K., Engelholm, L. H., and Behrendt, N. (2013) Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP: impact on lymphangiogenesis. J. Biol. Chem. 288, 10195-10204
45. Savinov, A. Y., and Strongin, A. Y. (2013) Targeting the T-cell membrane type-1 matrix metalloproteinase-CD44 axis in a transferred type 1 diabetes model in NOD mice. Exp. Ther. Med. 5, 438-442
46. Bergfeld, S. A., and DeClerck, Y. A. (2010) Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metastasis Rev. 29, 249-261
47. Umegaki, K., Sugisawa, A., Yamada, K., and Higuchi, M. (2001) Analytical method of measuring tea catechins in human plasma by solid phase extraction and HPLC with electrochemical detection. J. Nutr. Sci. Vitaminol. 47, 402-408